An overview of glycemic control in the coronary care unit with recommendations for clinical management

J Diabetes Sci Technol. 2009 Nov 1;3(6):1342-51. doi: 10.1177/193229680900300614.

Abstract

The observation that elevated glucose occurs frequently in the setting of acute myocardial infarction was made decades ago. Since then numerous studies have documented that hyperglycemia is a powerful risk factor for increased mortality and in-hospital complications in patients with acute coronary syndromes. While some questions in this field have been answered in prior investigations, many critical gaps in knowledge continue to exist and remain subjects of intense debate. This review summarizes what is known about the relationship between hyperglycemia, glucose control, and outcomes in critically ill patients with acute coronary syndromes, addresses the gaps in knowledge and controversies, and offers general recommendations regarding glucose management in the coronary care unit.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Acute Coronary Syndrome / blood
  • Acute Coronary Syndrome / complications*
  • Acute Coronary Syndrome / drug therapy
  • Acute Coronary Syndrome / mortality
  • Blood Glucose / drug effects*
  • Blood Glucose / metabolism
  • Coronary Care Units*
  • Critical Illness
  • Evidence-Based Medicine
  • Hospitalization
  • Humans
  • Hyperglycemia / blood
  • Hyperglycemia / diagnosis
  • Hyperglycemia / drug therapy*
  • Hyperglycemia / etiology
  • Hyperglycemia / mortality
  • Hypoglycemia / blood
  • Hypoglycemia / chemically induced
  • Hypoglycemia / diagnosis
  • Hypoglycemic Agents / administration & dosage*
  • Hypoglycemic Agents / adverse effects
  • Insulin / administration & dosage*
  • Insulin / adverse effects
  • Practice Guidelines as Topic
  • Practice Patterns, Physicians'
  • Risk Assessment
  • Risk Factors
  • Treatment Outcome

Substances

  • Blood Glucose
  • Hypoglycemic Agents
  • Insulin